EcoDrugPlus

Ribosomal Protein L30

Ensembl ID : ENSHCOG00000000794
Gene Symbol: RPL30
1 Cross references
54 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSHCOG00000009739
Gene Symbol: RPL31
3 Cross references
651 Possible Orthologues:

Ribosomal Protein L34

Ensembl ID : ENSHCOG00000015061
Gene Symbol: RPL34
3 Cross references
362 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSHCOG00000001654
Gene Symbol: RPL35
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSHCOG00000006386
Gene Symbol: RPL35A
3 Cross references
452 Possible Orthologues:

Ribosomal Protein L36

Ensembl ID : ENSHCOG00000007716
Gene Symbol: RPL36
3 Cross references
400 Possible Orthologues:

Ribosomal Protein L36a

Ensembl ID : ENSHCOG00000007810
Gene Symbol: RPL36A
4 Cross references
293 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSHCOG00000003192
Gene Symbol: RPL37
3 Cross references
424 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSHCOG00000018583
Gene Symbol: RPL38
3 Cross references
200 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSHCOG00000017012
Gene Symbol: RPL39
3 Cross references
170 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSHCOG00000014929
Gene Symbol: RPL4
3 Cross references
344 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSHCOG00000008395
Gene Symbol: RPL5
4 Cross references
455 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).